Purchase Order HHSN302201700181P

Award Date 6/29/17

Potential Completion Date 7/28/17

Potential Value $21K

Federal Agency

National Human Genome Research Institute

Awardee

Illumina, Inc. KMW3CRWNAAF3

Ultimate Awardee

Not listed

NAICS Category

541711 - Research and Development in Biotechnology

PSC Category

6550 - In Vitro Diagnostic Substances, Reagents, Test Kits And Sets

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Not Competed under SAP

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Bethesda, MD 20892, USA

Solicitation Procedures

Simplified Acquisition

Number Of Offers Received

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

Similar Awards

Purchase Order HHSN302201700235P
The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $15,314.69 on August 23, 2017, with an ultimate completion date of September 22, 2017. Work is performed in North Bethesda, Maryland. The order covers sequencing reagents and consumables under firm fixed price terms. No set-aside applied.
Purchase Order 75N92E18P00187
The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $15,314.69 on July 31, 2018, with final completion by August 29, 2018. The order is firm fixed price with no set-aside. Performance occurs in Bethesda, Maryland. The purchase order procures sequencing reagents, consumables, or related bioinformatics products from Illumina's core portfolio of DNA and RNA sequencing supplies and software.
Purchase Order HHSN302201700220P
The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $8,182.85 on August 15, 2017, with ultimate completion on September 14, 2017. Place of performance is Bethesda, Maryland. The order procures sequencing reagents, consumables, or related products under firm fixed price terms. No set-aside was applied.
Purchase Order HHSN302201700229P
The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $16,285.00 on August 15, 2017, with a completion date of December 1, 2017. No set-aside was used. Place of performance is Bethesda, Maryland. The order covers sequencing reagents, consumables, or related bioinformatics supplies, consistent with Illumina's core product line of DNA and RNA sequencing instruments and materials. Pricing is firm fixed price.
Purchase Order 75N92E19P00047
The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $17,735.76 on December 21, 2018, with completion by December 25, 2019. The order is a firm fixed price acquisition with no set-aside. Work is performed at Bethesda, Maryland. The purchase order procures DNA and RNA sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product lines serving federal health and research agencies.
Purchase Order HHSN302201700226P
The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $22,572.40 on August 18, 2017, with ultimate completion on September 17, 2017. The order is firm fixed price with no set-aside. Performance takes place in North Bethesda, Maryland. The procurement covers sequencing reagents, consumables, or related biotechnology products consistent with Illumina's core offerings to NIH institutes.
Purchase Order HHSN302201700206P
The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $21,912.66 on August 2, 2017, with performance completion by September 1, 2017. Work is performed in Bethesda, Maryland. The order procures sequencing reagents, consumables, or related bioinformatics materials—Illumina's core product offerings to federal research agencies. No set-aside category applies.
Purchase Order HHSN302201800016P
The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $9,715.00 on October 19, 2017, with an ultimate completion date of November 18, 2017. Work is performed in North Bethesda, Maryland. The order is firm fixed price with no set-aside. The source does not specify the technical scope of materials or services procured under this purchase order.
Purchase Order 75N92E18P00223
The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. valued at $19,792.44 on August 15, 2018, for DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software. Performance is at North Bethesda, Maryland, with an ultimate completion date of September 14, 2018. The order carries firm fixed price terms and no set-aside designation.
Purchase Order 75N92E18P00108
The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. valued at $7,074.60 for firm fixed price on May 1, 2018, with completion by May 31, 2018. Performance occurs in North Bethesda, Maryland. The order procures sequencing reagents and consumables aligned with Illumina's core portfolio of DNA and RNA sequencing products and bioinformatics support.

The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $21,323.61 on June 29, 2017, with ultimate completion on July 28, 2017. No set-aside was used. Work is performed in Bethesda, Maryland. The order covers sequencing reagents, consumables, or related bioinformatics products under firm fixed pricing. The purchase order represents a simplified acquisition for commercial items within Illumina's established federal footprint of DNA and RNA sequencing instruments and supplies.

Generated 8/1/26, 9:51 AM